Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes

Autor: Myung Ho Jeong, Christophe Piot, Jérôme Rischner, Fernando Lozano, Tae Hoon Ahn, Bruno García del Blanco, Victoria Vilalta del Olmo, Byung-Chun Jung, Peter Krajči, Petr Tousek, Matthias Waliszewski, Lucie Wachowiak, Koldobika Garcia-San Roman, Michel Pansieri, Matthias Leschke, Eduard Fernandez Nofrerias, Kyu-Rock Han, Wan Azman Wan Ahmad, Milan Trenčan, Laurent Sebagh, Bronislav Janek, Viktor Kočka, Imanol Otaegui Irurueta, Florian Krackhardt

Publikováno v: PLoS ONE, Vol 15, Iss 1, p e0226606 (2020)
PLoS ONE
PLoS ONE, Public Library of Science, 2020, 15 (1), pp.e0226606. ⟨10.1371/journal.pone.0226606⟩
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background The objective of this study was to assess regional and ethnic differences in an unselected patient population treated with polymer-free sirolimus-eluting stents (PF-SES) in Asia and Europe. Methods Two all-comers observational studies base

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272f90264c13a22b10e7e4042e1827bc
https://doaj.org/article/7dad4a5329ea4ad0a22d63cbd997dd3d

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

Autor: Florence Boisgerault, Federico Mingozzi, Romain Hardet, Helena Costa Verdera, Giuseppe Ronzitti, Alicia M. Michaud, Fanny Collaud, Amine Meliani, Giorgia Manni, Severine Charles, Alban Vignaud, Christian Leborgne, Petr Ilyinskii, Takashi Kei Kishimoto, Marcelo Simon Sola, Francesca Fallarino, Olivier D. Christophe, Solenne Marmier, Christopher J. Roy, Laetitia van Wittenberghe

Publikováno v: Nature Communications
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩

Gene therapy mediated by recombinant adeno-associated virus (AAV) vectors is a promising treatment for systemic monogenic diseases. However, vector immunogenicity represents a major limitation to gene transfer with AAV vectors, particularly for vecto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e609f78e07de4ba083e8423956027be
http://hdl.handle.net/11391/1439292

The TP53INP2 Protein Is Required for Autophagy in Mammalian Cells

Autor: Guillermo Velasco, Jean-Charles Dagorn, Marie-Josèphe Pébusque, J. Tardivel-Lacombe, Maria I. Vaccaro, Pierre Pontarotti, Cendrine Archange, Jonathan Nowak, Juan L. Iovanna

Publikováno v: Molecular Biology of the Cell
Molecular Biology of the Cell, American Society for Cell Biology, 2009, 20 (3), pp.870-81. ⟨10.1091/mbc.E08-07-0671⟩
Molecular Biology of the Cell, 2009, 20 (3), pp.870-81. ⟨10.1091/mbc.E08-07-0671⟩

International audience; Using a bioinformatic approach, we identified a TP53INP1-related gene encoding a protein with 30% identity with tumor protein 53-induced nuclear protein 1 (TP53INP1), which was named TP53INP2. TP53INP1 and TP53INP2 sequences w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c5f75ef18d0e83a29aa83ecbd3ce6f
https://doi.org/10.1091/mbc.e08-07-0671

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study

Autor: Pierre Merville, Marie-Christine Moal, Jacques Dantal, Christophe Legendre, Nassim Kamar, Stéphane Quéré, Jean Philippe Rerolle, Bruno Moulin, Fabienne Di Giambattista, Laetitia Albano, Rachel Tetaz, Olivier Toupance, Arara Terpereau, Eric Alamartine

Publikováno v: Annals of Transplantation
Annals of Transplantation, Springer Verlag (Germany), 2014, 17 (1), pp.58-67
Annals of Transplantation, 2014, 17 (1), pp.58-67

International audience; BACKGROUND: Data in kidney transplant recipients regarding elimination of calcineurin inhibitor (CNI) therapy from a de novo regimen based on low CNI exposure and an mTOR inhibitor are sparse, and restricted to CNI elimination

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0357f0eb3b9d101e32831b851411ba
http://www.hal.inserm.fr/inserm-00925721

Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study

Autor: Isabelle Etienne, Pierre-François Westeel, Thierry Frouget, Yvon Lebranchu, B. Hurault de Ligny, Jean-Philippe Rerolle, Etienne Thervet, Antoine Thierry, Sandrine Girardot-Seguin, Bruno Moulin, Olivier Toupance, Mathias Büchler

Publikováno v: American Journal of Transplantation
American Journal of Transplantation, 2011, 11 (8), pp.1665-75. ⟨10.1111/j.1600-6143.2011.03637.x⟩
American Journal of Transplantation, Wiley, 2011, 11 (8), pp.1665-75. ⟨10.1111/j.1600-6143.2011.03637.x⟩
American Journal of Transplantation, Wiley, 2011, 11 (8), pp.1665-75. 〈10.1111/j.1600-6143.2011.03637.x〉

International audience; Calcineurin inhibitor (CNI) withdrawal has been used as a strategy to improve renal allograft function. We previously reported that conversion from cyclosporine A (CsA) to sirolimus (SRL) 3 months after transplantation signifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6de94d50a9ce4a7b45d3a3ff29ebc2
https://www.hal.inserm.fr/inserm-00926380